Docusign Inc. (DOCU) PT Raised to $80 at RBC Capital

RBC Capital analyst Alex Zukin raised the price target on Docusign Inc. (NASDAQ: DOCU) to $80.00 (from $75.00) while maintaining an Outperform rating.

The analyst commented, "We hosted meetings with DocuSign's CFO Mike Sheridan and VP of IR Annie Leschin. After a strong 2Q, the company was full of good news. Management appeared incrementally confident across business fundamentals, demand, growth, and competition. We gained increased conviction around the opportunity for upside to numbers both short and longer term and are therefore comfortable increasing our price target to $80 and reiterating our Outperform rating."

You May Also Be Interested In

• ORIC Pharmaceuticals (ORIC) PT Raised to $27 at H.C. Wainwright
• Purple Biotech Ltd. (PPBT) PT Lowered to $17 at H.C. Wainwright
• Regenxbio Inc. (RGNX) PT Lowered to $23 at H.C. Wainwright